Fund Overlap
See which holdings any two equity ETFs have in common, along with top differences in exposure.
For overlap across multiple ETFs use Portfolio Builder
OVERLAP
36%
OVERLAP
BY WEIGHT
12
# OF OVERLAPPING
HOLDINGS
HRTS
42
HOLDINGS
29%
ALSO IN HART
HART
69
HOLDINGS
20%
ALSO IN HRTS
SECTOR DRIFT (HRTS minus HART)
OVERLAPPING HOLDINGS
Top 5 only shown here. Please log-in or sign up for a Basic (Free) membership to view the complete list.
| Company | Weight in HRTS |
Weight in HART |
Overlap | |
|---|---|---|---|---|
 |
ELI LILLY & CO | 11.5% | 6.4% | 6.4% |
|
UNITEDHEALTH GROUP INC | 5.2% | 6.0% | 5.2% |
 |
ASTRAZENECA PLC | 4.0% | 6.2% | 4.0% |
|
JOHNSON & JOHNSON | 3.6% | 7.2% | 3.6% |
 |
NOVARTIS AG | 3.4% | 6.4% | 3.4% |
HRTS Overweight Relative to HART
|
ELI LILLY & CO | 5.1% |
|
ROCHE HOLDINGS LTD-SPONS ADR | 4.5% |
|
MERCK & CO. INC. | 4.3% |
|
THERMO FISHER SCIENTIFIC INC | 4.0% |
|
GILEAD SCIENCES INC | 3.4% |
|
REVOLUTION MEDICINES, INC. | 3.3% |
|
VERTEX PHARMACEUTICALS INC | 2.9% |
|
DANAHER CORP | 2.7% |
|
BRIDGEBIO PHARMA, INC. | 2.6% |
|
ABBVIE INC | 2.4% |
HRTS Underweight Relative to HART
|
ALPHABET INC. CLASS A | -11.1% |
|
APPLE INC | -6.9% |
|
PFIZER INC | -5.5% |
|
JOHNSON & JOHNSON | -3.6% |
 |
SANOFI-AVENTIS | -3.4% |
|
NOVARTIS AG | -3.0% |
|
ELEVANCE HEALTH INC | -2.7% |
|
HCA HOLDINGS INC | -2.5% |
|
ASTRAZENECA PLC | -2.3% |
|
BRISTOL-MYERS SQUIBB CO | -1.7% |